David Broser

Director at Gliknik

Capital raised by Gliknik

$16.3M+$11.0M latest round

2 Form D filings · first filed Nov 2024 · Baltimore, MD

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 2
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

GliknikBiotech · Baltimore, MDsince Nov 2024

Director

Listed on Gliknik's Form D filings

Company filings

via EDGAR · Form D for Gliknik2

DateCompanyFormAmountRole on filing

Aug 15, 2025GliknikForm D+$11.0M—

Form DAug 15, 2025 · Gliknik+$11.0Mnot a signer

Nov 6, 2024GliknikForm D/A+$5.3M—

Form D/ANov 6, 2024 · Gliknik+$5.3Mnot a signer

Overview

Last filing Aug 15, 2025

David Broser is on file as Director at Gliknik in Baltimore, MD. Gliknik has 2 Form D filings on record, $16.3M raised in total.

Teammates

Gliknik · 1

David S. BlockCEO and PresidentSigner

Products

Gliknik · 1

GL-2045Biologics

GL-2045 is a recombinant Fc fusion protein developed to emulate the therapeutic effects of intravenous immunoglobulin (IVIG), providing a potentially more effective option for treating various autoimmune diseases.